scispace - formally typeset
Open AccessJournal ArticleDOI

Alzheimer's disease as homeostatic responses to age-related myelin breakdown

Reads0
Chats0
TLDR
This work delineates empirically testable mechanisms of action for genes underlying FAD and LOAD and provides "upstream" treatment targets and reframes key observations such as axonal transport disruptions, formation of axonal swellings/sphenoids and neuritic plaques, and proteinaceous deposits as by-products of homeostatic myelin repair processes.
Citations
More filters
Journal ArticleDOI

Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments.

TL;DR: It is suggested that widely used psychotropic treatments have under-appreciated CNS metabolic and neurotransmitter effects on myelination, its plasticity, and repair that may substantially contribute to their mechanisms of action.
Journal ArticleDOI

Normal-appearing cerebral white matter in healthy adults: mean change over 2 years and individual differences in change.

TL;DR: Analysis of 2-year WM change in 96 healthy adults revealed age-related differences in all WM indices across the regions, and the role of metabolic factors in shaping trajectories of brain aging was highlighted.
Journal ArticleDOI

Potential role of antimicrobial peptides in the early onset of Alzheimer's disease

TL;DR: A role for labeled AMPs are postulated as a marker to target pathogens that play a role in the aggregation of amyloid in the brain, based on existing literature.
Journal ArticleDOI

Disruption of oligodendrocyte progenitor cells is an early sign of pathology in the triple transgenic mouse model of Alzheimer’s disease

TL;DR: OPC disruption is an early pathological sign in AD and is a potential factor in accelerated myelin loss and cognitive decline, as deduced from significant changes in total cell surface area, total cell volume, somata volume and branching of main processes.
References
More filters
Journal ArticleDOI

The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

TL;DR: It has been more than 10 years since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide in plaques in brain tissue and the rest of the disease process is proposed to result from an imbalance between Aβ production and Aβ clearance.
Journal ArticleDOI

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

TL;DR: The APOE-epsilon 4 allele is associated with the common late onset familial and sporadic forms of Alzheimer9s disease (AD) in 42 families with late onset AD.
Journal ArticleDOI

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment.

TL;DR: Both linear regressions and multivariate analyses correlating three global neuropsychological tests with a number of structural and neurochemical measurements performed on a prospective series of patients with Alzheimer's disease and 9 neuropathologically normal subjects reveal very powerful correlations with all three psychological assays.
Journal ArticleDOI

Alzheimer's Disease Is a Synaptic Failure

TL;DR: Mounting evidence suggests that this syndrome begins with subtle alterations of hippocampal synaptic efficacy prior to frank neuronal degeneration, and that the synaptic dysfunction is caused by diffusible oligomeric assemblies of the amyloid β protein.
Related Papers (5)